Live attenuated vaccine · VDDBV0604
Note: 18 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT00969436 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT00861744 | Phase 2 | Varicella; Rubella; Mumps; Measles |
| NCT01991899 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT00388440 | Approved | Varicella; Rubella; Mumps; Measles |
| NCT00751348 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT02058563 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT01621802 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT02184572 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT01681992 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT01702428 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT00892775 | Phase 2 | Varicella; Rubella; Mumps; Measles |
| NCT01506193 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT00226499 | Phase 3 | Varicella; Rubella; Mumps; Measles |
| NCT00578175 | Phase 2 | Varicella; Rubella; Mumps; Measles |